Copyright
©The Author(s) 2004.
World J Gastroenterol. Mar 1, 2004; 10(5): 703-706
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.703
Published online Mar 1, 2004. doi: 10.3748/wjg.v10.i5.703
Table 2 Serum content of ALT, AST, HA and LN
Group | ALT (u/L) | AST (u/L) | HA (µg/L) | LN (µg/L) |
Normal | 52.5 ± 9.2a | 137.8 ± 18.7a | 178 ± 58a | 59.8 ± 21.8a |
Model | 165.6 ± 32.7ace | 257.4 ± 22.6c | 550 ± 68c | 130.0 ± 30.5c |
Colchicine | 96.2 ± 20.9c | 215.8 ± 24.6c | 416 ± 135c | 106.3 ± 14.2c |
AF | 65.8 ± 26.5a | 150.8 ± 34.0a | 228 ± 83ac | 85.9 ± 15.0c |
AS | 67.3 ± 18.4a | 154.6 ± 27.3a | 216 ± 58ac | 80.6 ± 18.6c |
- Citation: He YT, Liu DW, Ding LY, Li Q, Xiao YH. Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis. World J Gastroenterol 2004; 10(5): 703-706
- URL: https://www.wjgnet.com/1007-9327/full/v10/i5/703.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i5.703